Sanofi

FDA Action Alert: Regeneron, Sanofi, Celgene
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
FDA
drug approvals
Acer Therapeutics
Edsivo
Regeneron
Sanofi
Dupixent
Celgene
Revlimid
Alexion
Soliris
Dova Pharmaceuticals
Doptelet
Nabriva Therapeutics
Contepo
Retrophin
Thiola
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Flag link:
Rivals’ disappointing results in asthma trial drag down shares of Anaptys Bio
Rivals’ disappointing results in asthma trial drag down shares of Anaptys Bio
Stat
Sanofi
Regeneron
IL-33
asthma
monoclonal antibodies
REGN3500
AnaptysBio
Dupixent
Flag link:
Abbvie proves the best at getting the most out of its workers
Abbvie proves the best at getting the most out of its workers
EP Vantage
AbbVie
Bristol-Myers Squibb
Sanofi
AstraZeneca
revenue per employee
Flag link:
Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?
Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?
Biopharma Dive
Sanofi
M&A
Bioverativ
hemophilia
gene therapy
Flag link:
Sanofi to ax 466 jobs, step up focus on cancer, gene therapy R&D
Sanofi to ax 466 jobs, step up focus on cancer, gene therapy R&D
Fierce Biotech
Sanofi
layoffs
Germany
France
R&D
immuno-oncology
gene therapy
Flag link:
Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement
Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement
Fierce Pharma
Sanofi
bloodthinners
Lovenox
generics
Amphastar
Momenta
Sandoz
Flag link:
Sanofi and Google join forces to create ‘Innovation Lab’
Sanofi and Google join forces to create ‘Innovation Lab’
Pharmaforum
Sanofi
Google
innovation
Flag link:
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Biopharma Dive
Sanofi
diabetes
ADA
Soliqua
clinical trials
Flag link:
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Forbes
The Medicines Company
Amgen
Sanofi
Regeneron
inclisiran
PCSK9 inhibitors
Flag link:
Sanofi's Leadership Transition: What You Need To Know
Sanofi's Leadership Transition: What You Need To Know
Yahoo/Benzinga
Sanofi
Pharma CEOs
Paul Hudson
Olivier Brandicourt
Flag link:
A struggling Sanofi is preparing to hire Novartis senior pharma exec Paul Hudson as new CEO, replacing Brandicourt -- report
A struggling Sanofi is preparing to hire Novartis senior pharma exec Paul Hudson as new CEO, replacing Brandicourt -- report
Endpoints
Sanofi
Pharma CEOs
Novartis
Paul Hudson
Olivier Brandicourt
Flag link:
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Fierce Pharma
China
Sanofi
Eli Lilly
Bristol-Myers Squibb
Flag link:
#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait
#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait
Endpoints
Sanofi
Multiple Myeloma
isatuximab
ASCO 2019
Flag link:
Mark Your Calendar For These June PDUFA Dates
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Flag link:
Go or no go? Merck, Regeneron and Alexion await US expansion
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Merck
Keytruda
Sanofi
Regeneron
Dupixent
Alexion
Soliris
FDA
Dova Pharmaceuticals
Retrophin
Flag link:
Verily lures major pharmas with promise of speedier clinical research
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Verily
Alphabet
clinical trials
Pfizer
Novartis
Sanofi
Otsuka
Flag link:
Sanofi Joins Drugmakers' Bid to Treat Patients With Software
Sanofi Joins Drugmakers' Bid to Treat Patients With Software
Yahoo/Bloomberg
Sanofi
digital pharma
Happify Health
digital therapeutics
depression
multiple sclerosis
Flag link:
Vendu! Weeks after Sanofi cuts ties to Alnylam, the pharma giant offloads $842M of its stock
Vendu! Weeks after Sanofi cuts ties to Alnylam, the pharma giant offloads $842M of its stock
Endpoints
Sanofi
Alnylam
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
Flag link:

Pages